Science Explorer Back to mapMap
Discussion
Company · Nashville · United States

Cumberland Pharmaceuticals (United States)

cumberlandpharma.comROR OpenAlex
Research works
16
▲ 6% vs 2018-21
Citations
537
34.5 per fractional work
Top-10% rate
13.8%
all institutions 10.0%
Open access
46%
world 40%
International
4%
world 18%
Cumberland Pharmaceuticals (United States)

Not ranked overall: Cumberland Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Cumberland Pharmaceuticals (United States) work in?

In all years, 63% of research at Cumberland Pharmaceuticals (United States) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (63%), Biochemistry, Genetics and Molecular Biology (19%), Engineering (6%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 10 fractional works · 63.5% of its workMedicine: 10 fractional works · 62.8% of its workPharmacology: 2 fractional works · 13.9% of its workSurgery: 2 fractional works · 13.2% of its workCritical Care and Intensive Care Medicine: 1 fractional works · 5.5% of its workPsychiatry and Mental health: 1 fractional works · 3.9% of its workPulmonary and Respiratory Medicine: 1 fractional works · 3.9% of its workAnesthesiology and Pain Medicine: 0 fractional works · 3.2% of its workEmergency Medicine: 0 fractional works · 3.0% of its workEpidemiology: 0 fractional works · 2.4% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 2.3% of its workPhysiology: 0 fractional works · 1.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.2% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.1% of its workGastroenterology: 0 fractional works · 1.1% of its workHepatology: 0 fractional works · 1.1% of its workInternal Medicine: 0 fractional works · 1.1% of its workInfectious Diseases: 0 fractional works · 1.0% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workOncology: 0 fractional works · 0.7% of its workHematology: 0 fractional works · 0.6% of its workHealth Professions: 0 fractional works · 0.7% of its workGeneral Health Professions: 0 fractional works · 0.4% of its workHealth Information Management: 0 fractional works · 0.4% of its workLife Sciences: 4 fractional works · 24.8% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 19.0% of its workMolecular Biology: 2 fractional works · 14.8% of its workGenetics: 0 fractional works · 2.8% of its workCancer Research: 0 fractional works · 1.1% of its workCell Biology: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 2.5% of its workPharmacology: 0 fractional works · 1.4% of its workToxicology: 0 fractional works · 1.1% of its workAgricultural and Biological Sciences: 0 fractional works · 1.8% of its workFood Science: 0 fractional works · 1.1% of its workAnimal Science and Zoology: 0 fractional works · 0.7% of its workImmunology and Microbiology: 0 fractional works · 1.0% of its workImmunology: 0 fractional works · 0.6% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.5% of its workPhysical Sciences: 1 fractional works · 9.2% of its workEngineering: 1 fractional works · 6.4% of its workAutomotive Engineering: 0 fractional works · 3.2% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 3.2% of its workEnvironmental Science: 0 fractional works · 2.1% of its workEcology: 0 fractional works · 2.1% of its workChemistry: 0 fractional works · 0.3% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 0.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 2.5% of its workSocial Sciences: 0 fractional works · 1.4% of its workHealth: 0 fractional works · 0.7% of its workSociology and Political Science: 0 fractional works · 0.7% of its workBusiness, Management and Accounting: 0 fractional works · 0.7% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.7% of its workDecision Sciences: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.2% of its workALL ITS WORKCumberlandPharmaceuticals…16fractional works, all years
Life Sciences25%Physical Sciences9%Health Sciences63%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine1062.8%
    2. Health Professions00.7%
    1. Biochemistry, Genetics and Molecular Biology319.0%
    2. Pharmacology, Toxicology and Pharmaceutics02.5%
    3. Agricultural and Biological Sciences01.8%
    4. Immunology and Microbiology01.0%
    5. Neuroscience00.5%
    1. Engineering16.4%
    2. Environmental Science02.1%
    3. Chemistry00.3%
    4. Computer Science00.3%
    1. Social Sciences01.4%
    2. Business, Management and Accounting00.7%
    3. Decision Sciences00.2%
    4. Economics, Econometrics and Finance00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.05× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 6.14× its world share, 0 worksImmunology and Micro…Neuroscience: 2.15× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 19.81× its world share, 0 worksPharmacology, Toxico…Health Professions: 1.77× its world share, 0 worksHealth ProfessionsMedicine: 3.25× its world share, 2 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 19.8×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics19.81×0 works
  2. Immunology and Microbiology6.14×0 works
  3. Medicine3.25×2 works
  4. Biochemistry, Genetics and Molecular Biology3.05×0 works
  5. Neuroscience2.15×0 works
  6. Health Professions1.77×0 works

Who are the top researchers at Cumberland Pharmaceuticals (United States)?

Ranked on the quality score, Leo Pavliv and Ines Macias‐Perez lead among researchers whose main affiliation is Cumberland Pharmaceuticals (United States).

  1. 1 Leo Pavliv United States · #1,728,950 worldwide 532 citations · 17 works
  2. 2 Ines Macias‐Perez United States · #1,797,984 worldwide 746 citations · 25 works
All ranked researchers at Cumberland Pharmaceuticals (United States)

What are the most cited papers from Cumberland Pharmaceuticals (United States)?

The most cited paper from Cumberland Pharmaceuticals (United States) is "Efficacy and Safety of Ibuprofen and Acetaminophen in Children and Adults: A Meta-Analysis and Qualitative Review" (Catherine A. Pierce, Bryan Voss, 2010), with 266 citations. Next come "A multicenter, randomized, double-blind, placebo- controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain" (138) and "A multicenter, randomized, double‐blind placebo‐controlled, single dose trial of the safety and efficacy of intravenous ibuprofen for treatment of pain in pediatric patients undergoing tonsillectomy" (103).

Most cited papers
#PaperReleasedCitations
1 Efficacy and Safety of Ibuprofen and Acetaminophen in Children and Adults: A Meta-Analysis and Qualitative Review Catherine A. Pierce, Bryan Voss · Annals of Pharmacotherapy Review 11 Feb 2010 266
2 A multicenter, randomized, double-blind, placebo- controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain Stephen R. Southworth, Jeannine Peters, Amy D. Rock et al. · Clinical Therapeutics Sep 2009 138
3 A multicenter, randomized, double‐blind placebo‐controlled, single dose trial of the safety and efficacy of intravenous ibuprofen for treatment of pain in pediatric patients undergoing tonsillectomy Jonathan R. Moss, Mehernoor F. Watcha, Laima P. Bendel et al. · Pediatric Anesthesia Open access 20 Mar 2014 103
4 A Multi-Center, Randomized, Double-Blind Placebo-Controlled Trial of Intravenous-Ibuprofen (IV-Ibuprofen) for Treatment of Pain in Post-Operative Orthopedic Adult Patients Neil Singla, Amy D. Rock, Leo Pavliv · Pain Medicine Open access 6 Jul 2010 96
5 A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial of Intravenous Ibuprofen (IV‐Ibuprofen) in the Management of Postoperative Pain Following Abdominal Hysterectomy Peter B Kroll, Laura Meadows, Amy D. Rock et al. · Pain Practice 19 Jul 2010 87
All 39 most cited papers, with filters and sorting

Which research topics does Cumberland Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Antibiotics Pharmacokinetics and Efficacy, Pharmacovigilance and Adverse Drug Reactions, Drug-Induced Adverse Reactions and Inflammatory mediators and NSAID effects.

Antibiotics Pharmacokine…0Antibiotics Pharmacokinetics and Efficacy: 0 fractional worksPharmacovigilance and Ad…0Pharmacovigilance and Adverse Drug Reactions: 0 fractional worksDrug-Induced Adverse Rea…0Drug-Induced Adverse Reactions: 0 fractional worksInflammatory mediators a…0Inflammatory mediators and NSAID effects: 0 fractional worksPediatric Pain Management Techniques: 0 fractional worksOrthopedic Infections and Treatments: 0 fractional worksAdrenal Hormones and Dis…0Adrenal Hormones and Disorders: 0 fractional worksBacillus and Francisella bacterial research: 0 fractional worksBacterial Genetics and Biotechnology: 0 fractional worksErythropoietin and Anemi…0Erythropoietin and Anemia Treatment: 0 fractional works
PharmacologyToxicologyPediatrics, Perinatology and Child HealthSurgery4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
  2. 2 Pharmacovigilance and Adverse Drug Reactions Toxicology 0 works
  3. 3 Drug-Induced Adverse Reactions Pharmacology 0 works
  4. 4 Inflammatory mediators and NSAID effects Pharmacology 0 works
  5. 5 Pediatric Pain Management Techniques Pediatrics, Perinatology and Child Health 0 works
  6. 6 Orthopedic Infections and Treatments Surgery 0 works
  7. 7 Adrenal Hormones and Disorders Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Bacillus and Francisella bacterial research Molecular Biology 0 works
  9. 9 Bacterial Genetics and Biotechnology Genetics 0 works
  10. 10 Erythropoietin and Anemia Treatment Hematology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.0%not open54.0%

World: 40% of research is openly available.

with international co-authors3.8%domestic only96.2%

World: 18% is written across borders.

How has Cumberland Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 6% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Cumberland Pharmaceuticals (United States) as a percentage of every work published that year, 0.0000060% in 2024.

still counting0.000050%0.00010%0.00015%Cumberland Pharmaceuticals (United States)0.000024% in 202520102020

Fractional works of Cumberland Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Nashville

All research institutions in Nashville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Cumberland Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.